A new study finds that access to abortion services expanded greatly in the five years after the abortion pill was approved and pharmacies began dispensing it in Ontario.
Research published in the Canadian Medical Association Journal this morning says that most people in Ontario did not have access to abortion services in 2017.
But they say access in urban and rural areas increased from 37 per cent in 2017 to 91 per cent in 2022.
Researchers peg that to eased regulations for pharmacists to dispense Mifegymiso, the brand name for a combination of two medications taken consecutively, mifepristone and misoprostol, approved by Health Canada in 2017.
The study looked at population-based health administrative data from 2017 to 2022.
The study found the drug was used in 56 per cent of abortions in 2022, up from about eight per cent in 2017.
Story continues below advertisement
Lead author Laura Schummers says the study shows how …